Health

Results: 589-600 of 9180

PR Newswire associated0

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

Business Wire associated0

Viz.ai Launches Viz Pulmonary Suite, the First Comprehensive AI-Powered Solution Dedicated to Pulmonary Care Delivery

SBC Medical Group Holdings Announces First Quarter 2026 Financial Results

Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026

AviadoBio Presents Positive Preclinical Data for AVB-406 Program in Alzheimer’s Disease and Other Tauopathies at ASGCT 2026

PR Newswire associated0

Bupa and YuLife launch innovative Cash Plan to improve workplace health

ASTRAZENECA’S IMFINZI (DURVALUMAB) RECOMMENDED BY NICE FOLLOWING MHRA APPROVAL AS FIRST IMMUNOTHERAPY IN COMBINATION WITH PERIOPERATIVE CHEMOTHERAPY IN RESECTABLE GASTRIC OR GASTRO-OESOPHAGEAL JUNCTION CANCER

PR Newswire associated0

Wellcome launches world's largest global prize for mental health science

PR Newswire associated0

GenesisCare and SeeTreat to bring personalised Offline Adaptive Monitoring to more than 40 radiation oncology centres across Australia

BeOne Medicines' flagship U.S. biologics manufacturing and clinical R&D facility at the Princeton West Innovation Campus in Hopewell, N.J.

BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma

PR Newswire associated0

New Partnership between SC Johnson, U.S. Department of State and the Global Fund Could Help Protect 60 Million People from Malaria

ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders